Company Overview and News

 
Aspire Mining receives strong placement support and lifts conditional raising to $2.1 million

2018-09-02 proactiveinvestors.com.au
Aspire Mining Ltd (ASX:AKM) has received strong pre-commitments for the minimum placement condition needed to complete a $15 million strategic financing package and will increase the placement to $2.1 million.
ASPXF AKM

 
Funding commitments firm up Aspire Mining’s near-production Ovoot project

2018-08-31 proactiveinvestors.com.au
Aspire Mining Ltd (ASX:AKM) managing director David Paull speaks to Proactive Investors about the development company’s recent work and financing arrangements at its Ovoot Coking Coal Project in Mongolia.
ASPXF AKM

 
Aspire Mining targets early development of world-class Mongolian coking coal project

2018-08-29 proactiveinvestors.com.au
Aspire Mining Ltd (ASX:AKM) is targeting early production of washed coal from the world-class Ovoot Coking Coal Project in northern Mongolia within 12 to 15 months of approval.
ASPXF AKM

 
Aspire Mining has strategic development and associated funding news pending, trading halt granted

2018-08-27 proactiveinvestors.com.au
Aspire Mining Ltd (ASX:AKM) has been granted a trading halt by the ASX pending news of a strategic development and associated funding package.
ASPXF AKM

 
Aspire Mining’s subsidiary granted extension to complete conditions relating to Mongolian rail concession

2018-08-13 proactiveinvestors.com.au
Aspire Mining Ltd’s (ASX:AKM) rail subsidiary Northern Railways LLC has been granted an 18-month extension to complete conditions relating to the Erdenet to Ovoot rail concession in northern Mongolia.
ASPXF AKM

 
Aspire Mining pleased with 'very good commercial outcomes' from rail feasibility study

2018-06-21 proactiveinvestors.com.au
Aspire Mining Ltd (ASX:AKM) managing director David Paull speaks to Proactive Investors about the review of a rail feasibility study, carried out by wholly-owned rail subsidiary Northern Railways LLC, with the support of China Gezhouba International Ltd. This 547.7 kilometer railway extension will connect Aspire Mining’s large-scale Ovoot Coking Coal Project to the the town of Erdenet, and form part of the proposed Northern Rail Corridor extending across northern Mongolia into southern Russia.
ASPXF AKM

 
Aspire Mining coking coal test results confirm premium product

2018-06-17 proactiveinvestors.com.au
Aspire Mining Ltd (ASX:AKM) has received results from pilot-scale carbonisation test work on a 300-kilogram bulk sample from its Nuurstei Coking Coal Project in Mongolia.
ASPXF AKM

 
Aspire Mining welcomes new Russia-Mongolia agreement lowering rail transit costs

2018-06-13 proactiveinvestors.com.au
Aspire Mining Ltd (ASX:AKM) stands to gain from the new cooperation agreement signed between Russia and Mongolia.
ASPXF AKM

 
Aspire Mining responds to ASX price and volume query

2018-06-12 proactiveinvestors.com.au
Aspire Mining Ltd (ASX:AKM) yesterday received a query from the ASX related to the company’s shares rising from 2.1 cents last Friday to 2.7 cents yesterday.
ASPXF AKM

 
Aspire Mining feasibility study review reduces railway construction cost

2018-06-04 proactiveinvestors.com.au
Aspire Mining Ltd (ASX:AKM) has completed its review of the 547.7-kilometre Erdenet to Ovoot rail feasibility study.
ASPXF AKM

 
Aspire Mining major shareholder purchases more stock on market

2018-05-30 proactiveinvestors.com.au
Aspire Mining Ltd (ASX:AKM) has had major shareholder, Tserenpuntsag Tserendamba, increase its stake in the company to 16.10% from 14.77%.
ASPXF AKM

 
Aspire Mining welcomes growing support for rail for its coal mine

2018-05-21 proactiveinvestors.com.au
Aspire Mining Ltd (ASX:AKM) stands to gain from the growing support for the Erdenet to Ovoot Railway from both within Mongolia and the Tuva Republic in the Russian Federation.
ASPXF AKM

 
Aspire Mining is one of the most traded stocks on the ASX today

2018-05-11 proactiveinvestors.com.au
Aspire Mining Ltd (ASX:AKM) is one of the most traded stocks today on the ASX by share volume.
ASPXF AKM

 
Aspire Mining receives speeding ticket from ASX after shares surge 25% under high volumes

2018-04-24 proactiveinvestors.com.au
In the absence of any news relating to those projects, the ASX has queried the share price spike.
ASXFF ASXFY ASPXF AKM

 
Aspire Mining on track with railway to exploit major Mongolian coking coal project

2018-04-20 proactiveinvestors.com.au
Aspire Mining Ltd (ASX:AKM) managing director David Paull says "as a relatively small cap company, we've got our foot on a real giant, and realising the value in that giant is really what we're aiming to do through this year." The company’s plans for 2018 are focused on developing coking coal deposits in Mongolia to deliver international specification product to neighbouring international consumers.
ASPXF AKM

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...